BGBIO — Bergenbio ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Bergenbio ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	254	722	437	151	156
Net Total Receivables	15.4	13.5	11.7	14.1	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	269	736	449	167	174
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.974	2.33	1.19	0.043	0.431
Other Long Term Assets
Total Assets	270	738	450	167	174
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	50.6	66.6	64.9	77.9	46.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	50.6	68	65.8	78.2	46.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	220	670	384	88.5	127
Total Liabilities & Shareholders' Equity	270	738	450	167	174
Total Common Shares Outstanding